Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Kuehn Law investigates Vistagen Therapeutics for alleged misrepresentation in clinical trial risks.

Market News
01 Jun 2026
Kuehn Law, Pllc
View Source
Bearish
pluang ai news

Kuehn Law, PLLC is investigating whether Vistagen Therapeutics' officers and directors breached their duties by misrepresenting risks in their Social Anxiety Disorder clinical trials. The lawsuit claims insiders failed to disclose high placebo responses and variability in Phase 2 trials but still promoted Phase 3 trial success. Shareholders who bought stock before April 1, 2024, are urged to contact the law firm to protect their rights. This case highlights potential governance issues affecting investor confidence in Vistagen Therapeutics.

More News

North Texas Food Banks and WFAA launch telethon to raise 1M meals for hungry children this summer.

North Texas Food Banks and WFAA launch telethon to raise 1M meals for hungry children this summer.

As summer begins, North Texas faces a surge in child hunger due to loss of school meals. WFAA, North Texas Food Bank, and Tarrant Area Food Bank are hosting the Nourish North Texas Telethon on June 11 to raise funds for at least one million meals for...

Others
Neutral
1 hour ago
AstraZeneca's liver cancer trial shows 30% progression-free survival improvement with new STRIDE regimen.

AstraZeneca's liver cancer trial shows 30% progression-free survival improvement with new STRIDE regimen.

AstraZeneca's Phase 3 EMERALD-3 trial demonstrated that the STRIDE regimen, combining immunotherapy drugs Imfinzi and Imjudo with lenvatinib and TACE, significantly improved progression-free survival by 30% compared to TACE alone in patients with unr...

Company Fundamentals
Bullish
1 hour ago
Motorola Solutions acquires counter-drone firm D-Fend for $1.5B to boost airspace security.

Motorola Solutions acquires counter-drone firm D-Fend for $1.5B to boost airspace security.

Motorola Solutions announced the acquisition of D-Fend Solutions, a leader in counter-drone technology, for $1.5 billion. This move aims to enhance Motorola's airspace security capabilities amid rising drone threats. D-Fend has shown over 50% annual ...

Market News
Bullish
1 hour ago
Quadient publishes details for its Annual and Extraordinary General Meeting on June 18, 2026

Quadient publishes details for its Annual and Extraordinary General Meeting on June 18, 2026

Quadient has released the official notice and agenda for its Ordinary Annual and Extraordinary General Meeting scheduled for June 18, 2026. Key documents including draft resolutions and participation details are available on the company's website and...

Company Fundamentals
Neutral
1 hour ago
Quadient releases documents for June 18, 2026 Annual and Extraordinary General Meeting

Quadient releases documents for June 18, 2026 Annual and Extraordinary General Meeting

Quadient has made available the preparatory documents for its Ordinary Annual and Extraordinary General Meeting scheduled for June 18, 2026. These documents, including the agenda and proposed resolutions by the Board of Directors, are accessible on Q...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App